Raising the Clinical Standard - Dentsply

Smooth Scaling Ahead Highlights
Needle-free Anaesthesia
Oraqix ® (25/25 mg per g
Ultrasonic Scalers
Cavitron Jet Plus and Cavitron
periodontal gel lidocaine, prilocaine) Plus Ultrasonic Scalers
•
•
•
•
•
Fast - 30 second onset provides 20 minutes
of anaesthesia (range 14 - 31).
Easy - Dispensed as a liquid, then sets
as a gel in the periodontal pocket.
Patient Comfort - Needle-free application
avoids patient concerns about needles
and injections.
Can be reapplied as needed to a maximum
of 5 cartridges per appointment.
Must administer Oraqix ® with the autoclavable
Oraqix Dispenser.
•
•
•
•
•
Wireless foot pedal - Never trip over
your scaler’s cable again!
SPS technology - Automatically adjusts
system power.
The Blue Zone - Power range for
deposit removal.
Automatic purge - Ease-of-maintenance
between patients.
Rinse Mode - Lavage feature for
maximum antimicrobial benefit.
Cavitron Ultrasonic Inserts
Bellissima , FSI ® , FSI ® Slimline and
SofTip Implant Inserts
• Wide variety of tip designs
for better access, adaptation,
and lavage.
• FSI ® patented water delivery
enhances clinician visibility
and patient comfort.
• Ergonomic 30K Bellissima Inserts
have a soft, dimpled grip for
clinician comfort and reduced hand
fatigue, available with FSI ® and FSI ®
SLI ® insert tip designs.
• SofTip Implant Insert removes
plaque and calculus around
titanium implants and abutments.
UKP00095 Date of preparation: November 2007
ORAQIX 25/25 mg per g periodontal gel: Lidocaine, Prilocaine. PRESENTATION: Clear, colourless gel with 1g containing 25mg lidocaine and 25mg prilocaine. USES: Indicated in adults for
localised anaesthesia in periodontal pockets for diagnostic and treatment procedures such as probing, scaling and/or root planing in adults. DOSAGE AND ADMINISTRATION: For adults one
cartridge (1.7 g) or less is sufficient for one quadrant of dentition. Maximum recommended dose is five cartridges (8.5 g gel). Oraqix has not been studied in paediatric patients. Apply with metric
dental syringe or Oraqix Dispenser. Fill the periodontal pockets with Oraqix until the gel becomes visible at the gingival margin. Wait 30 sec before starting treatment. CONTRAINDICATIONS,
PRECAUTIONS, WARNINGS ETC: Contraindications: Hypersensitivity to lidocaine, prilocaine, amide-type local anaesthetics or any excipients. Congenital or idiopathic methaemoglobinaemia,
recurrent porphyria. Precautions: Oraqix must not be injected. Use with caution in patients with severe impairment of renal function, hepatic function, impulse initiation and conduction of the heart,
patients in remission from porphyria or asymptomatic carriers of mutated genes responsible for porphyria. Patients with glucose-6-phosphate dehydrogenase deficiency are more susceptible to druginduced
methaemoglobinaemia. Do not apply to ulcerative lesions or during acute infections of oral cavity. Side-effects: Headache, local pain, soreness, numbness, ulcer, irritation, redness, reaction,
taste perversion, dizziness, pulsation, vesicles, oedema, burning, nausea. Allergic reactions. Methaemoglobinaemia, consider giving slow i.v. injection of methylene blue. Pregnancy: Avoid use in
pregnancy. Interactions: With sulphonamides. Observe caution in combination with other local anaesthetics or agents structurally related to amide-type local anaesthetics. PRECAUTIONS: Do not
freeze. PACKAGE QUANTITIES: Box of 20 cartridges and 20 dental applicators. LEGAL CATEGORY: POM. PRODUCT LICENCE NUMBER: 18344 DATE OF PREPARATION: October 2005.
FOR FURTHER INFORMATION CONTACT THE PRODUCT LICENCE HOLDER: DENTSPLY Ltd Hamm Moor Lane, Addlestone, Weybridge, Surrey, KT15 25E, England.
Adverse events should be reported to DENTSPLY Ltd or the MHRA. More information can be found at: www.yellowcard.gov.uk
(lidocaine and prilocaine
periodontal gel) 2.5% / 2.5%
®
DENTSPLY UK Ltd
Hamm Moor Lane
Weybridge, Surrey KT15 2SE
www.dentsply.com | www.dentsply.co.uk
+44 (0)1932 853422